San Francisco, CANCT07657182Now EnrollingIRB Ready

Peripheral Nerve Injury Clinical Trial in San Francisco, CA

Access cutting-edge peripheral nerve injury treatment through this phase 4 clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Axogen Corporation

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access peripheral nerve injury specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related peripheral nerve injury treatment provided free

Apply for This San Francisco Location

Check if you qualify for this peripheral nerve injury clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Peripheral Nerve Injury Study in San Francisco

This is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and Months 3, 6, 9, 12, 15, 18, 21, and 24.

Sponsor: Axogen Corporation

Who Can Participate

Inclusion Criteria

Study Participant Criteria
Be ≥ 18 years of age at the time of consent;
Willing and able to comply with all aspects of the treatment and evaluation schedule over a 24-month duration;
Provide documented Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved informed consent prior to initiation of any study procedures; Injury/Repair Criteria for Each Nerve
Primary or secondary nerve injury repair with sural nerve autograft or Avance Nerve Graft for fully transected reconstruction of the following upper extremity mixed and/or motor nerve(s):
Median nerve: proximal nerve stump within 20 cm from the center point of the thenar eminence and distal to the crease of the elbow;
Anterior interosseous nerve;
Median nerve recurrent motor branch;
Radial nerve: proximal nerve stump within 20 cm of the center of the forearm (midpoint between the tip of the olecranon and the styloid process) and distal to the mid-humerus;
Posterior interosseous nerve.
Zone of injury of eligible nerve(s) resectable to healthy nerve both distally and proximally and within the anatomical regions of Inclusion Criterion #4;
In study participants with multiple eligible nerve repairs, repair of all eligible nerves completed with the same study treatment, either Avance Nerve Graft or sural nerve autograft;
Measured nerve gap(s) following resection \> 25 mm;
Nerve(s) repaired ≤ 120 days post injury;
Undergo coaptation on both the proximal and distal portion of the nerve gap(s) per the USPI for Avance Nerve Graft and per standard of care for sural nerve autograft; and
Either treatment method, Avance Nerve Graft or sural nerve autograft, is a viable option for all eligible nerve repair(s) (i.e., volume of injured nerve\[s\] does not exceed availability of sural nerve autograft for reconstruction, study participants are not treated with a combination of treatment types).

Exclusion Criteria

Study Participant Criteria
Currently enrolled in another clinical study that may interfere with treatment, assessment of recovery, or participation in this study;
Deformities or injuries of the limb, hand, or digits that affect both the primary and secondary assessments for eligible nerve repair(s);
History of neuropathy of any etiology, diabetic neuropathy or any other known neuropathy including compressive/traumatic neuropathies affecting the target limb;
History of progressive neurodegenerative or autoimmune disorder affecting peripheral nerve or motor function (e.g., amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease);
History of chronic ischemic condition of the upper extremity;
Expected use of medication during the study that is known to impact nerve regeneration or to cause peripheral neuropathy;
Undergoing or expected to undergo treatment with chemotherapy, radiation therapy, or other known treatment which affects the growth of neural and/or vascular systems;
Participant is unlikely to comply with all study requirements and standard medical care procedures for the duration of the study schedule; Injury/Repair Criteria for Each Nerve
Median nerve repairs where the ulnar nerve has been transected due to injury or repair;
Repair(s) of a sensory-only proximal nerve stump;
Incomplete nerve transections;
Multilevel nerve injury pattern requiring two or more isolated reconstructions along the nerve pathway (for example, reconstruction of median nerve in forearm and recurrent motor branch resulting in repair pattern of graft to native nerve to graft to distal target);
Inadequate soft tissue coverage or extensive soft tissue injury which will impair recovery assessment;
Nerve avulsion injuries and nerve traction injuries resulting in rupture of the nerve;
Replantation/amputation of the limb, hand, or digits involved in both the primary and secondary assessments for eligible nerve repair(s);
Nerve repairs utilizing either end-to-side or side-to-side coaptation techniques;
Nerve transfer, tendon transfer, or other concomitant treatment at the time of nerve repair that affects assessment of function of the innervated muscle organ;
Use of coaptation devices that include metallic components or activated polymers and coaptations completed with fibrin glue only; and
Injuries with vascular damage resulting in inadequate perfusion despite repair (i.e., both radial and ulnar arteries injured \[one injured artery is allowed\]).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07657182) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Peripheral Nerve Injury Treatment Options in San Francisco, CA

If you're searching for peripheral nerve injury treatment options in San Francisco, CA, this clinical trial (NCT07657182) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced peripheral nerve injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all peripheral nerve injury clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in San Francisco, CA

See all pulmonary embolism clinical trials recruiting in San Francisco — not just this study.

Browse Pulmonary Embolism Trials in San Francisco →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA